Form 4 for INGN Inogen Inc
Accepted 2023-09-05 00:00:00 ET · period of report 2023-09-01 · accession 0001209191-23-048239 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-09-05 | 2023-09-01 | INGN | Shabshab Nabil | CEO, Pres, Dir | M - OptEx | $0.00 | +3,686 | 38.9K | +10% | $0 |
| D | 2023-09-05 | 2023-09-01 | INGN | Shabshab Nabil | CEO, Pres, Dir | F - Tax | $6.18 | -1,942 | 37.0K | -5% | -$12.0K |
| DM | 2023-09-05 | 2023-09-01 | INGN | Shabshab Nabil | CEO, Pres, Dir | M - OptEx | $0.00 | -3,686 | 4,234 | -47% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-09-01 | M | A | 3,686 | $0.00 | 38,933 | D | — | — | |
| 2 | Common | Common Stock | 2023-09-01 | F | D | 1,942 | $6.18 | 36,991 | D | — | — | (F1) The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on September 1, 2023. |
| 3 | Derivative | Restricted Stock Unit | 2023-09-01 | M | D | 1,569 | $0.00 | 4,704 | D | — · — to — | 1,569 Common Stock | (F2) Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. (F3) Subject to the reporting person's continued service with the Company, 25% of the restricted stock units will vest March 1, 2022, and the remaining 75% of the restricted stock units will vest in 1/12th quarterly installments over the following 3 years. |
| 4 | Derivative | Restricted Stock Unit | 2023-09-01 | M | D | 2,117 | $0.00 | 4,234 | D | — · — to — | 2,117 Common Stock | (F2) Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. (F4) Subject to the reporting person's continued service, 50% of the restricted stock units will vest on March 1, 2022, and the remaining 50% of the restricted stock units will vest in 1/8th quarterly installments over the following 2 years. |